^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    NETest®

    Company:
    Wren Laboratories
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    NETest, a non-invasive novel multi-gene liquid biopsy that measures neuroendocrine tumor gene expression in blood and has utility in identification of residual disease. This test examines the expression of 52 genes, which can be used to identify active disease and provide information about the biology of the tumor cell.
    Cancer:
    Neuroendocrine Tumor
    Method:
    Liquid biopsy
    Confirmatory trial(s)
    NCT02948946
    |
    Neuroendocrinology
    RegisterNET
    ,
    NCT02270567
    |
    The Oncologist